Advertisement
YOU ARE HERE: LAT HomeCollectionsJane E Henney
IN THE NEWS

Jane E Henney

FEATURED ARTICLES
NEWS
October 1, 1999 | From Times Wire Reports
The Food and Drug Administration will start a nationwide campaign today that will urge women to make sure they and their families take medications properly. As many as half of all Americans do not take their medications as directed, FDA Commissioner Jane E. Henney said. Mistakes can cause serious side effects that lead to doctor visits, hospital admissions and prescriptions that could have been avoided.
ARTICLES BY DATE
Advertisement
CALIFORNIA | LOCAL
March 21, 2000
First Lady and New York senatorial candidate Hillary Rodham Clinton's media event Monday to discuss the sharp rise in the number of young children using Ritalin, Prozac and other powerful psychiatric drugs addressed an urgent and legitimate problem. The number of children on Ritalin, for instance, nearly tripled in the mid-1990s. Ultimately, however, the event had a hollow feel, for Clinton's proposed solutions barely touched the underlying problems.
NEWS
January 18, 2001 | MARLENE CIMONS, TIMES STAFF WRITER
The Food and Drug Administration on Wednesday proposed making information available on all clinical trials involving gene therapy and animal-to-human transplants, including data about deaths or serious side effects.
NEWS
December 28, 1999 | JAMES GERSTENZANG, TIMES STAFF WRITER
The White House will announce today the government's first effort to crack down on the increasingly troublesome, and sometimes illegal, practice of selling prescription drugs on the Internet, senior officials said Monday. The measures, if approved by Congress, would propel the federal government directly into overseeing the online sale and distribution of pharmaceuticals to individual consumers.
NEWS
January 20, 2001 | MARLENE CIMONS, TIMES STAFF WRITER
Commissioner Jane E. Henney of the Food and Drug Administration, under whose stewardship the controversial abortion pill RU-486 was approved, has been told by the Bush administration that she will not be retained. Henney had submitted her resignation along with those of other political appointees, though she had reportedly expressed a desire to remain in the job. She was told late Thursday that her resignation would be accepted and to leave her office by the close of business Friday.
NEWS
March 15, 2000 | DAVID WILLMAN, TIMES STAFF WRITER
The Food and Drug Administration has opened an investigation into whether the manufacturer of the diabetes pill Rezulin improperly reported findings of liver injury among patients in early clinical research. The investigation, according to people familiar with the matter, comes as FDA Commissioner Jane E. Henney plans to meet about Rezulin today with a handful of senior aides, including Dr. Murray M. Lumpkin, the deputy drug-center director.
NEWS
January 22, 1998 | MARLENE CIMONS, TIMES STAFF WRITER
The Clinton administration reportedly is eager to name Dr. Jane E. Henney, vice president of the University of New Mexico Health Sciences Center, to fill the nearly yearlong vacancy created at the Food and Drug Administration by the resignation of its high-profile commissioner, Dr. David A. Kessler. Among her credentials--which include nearly a decade at the National Cancer Institute--is that she worked for Kessler for two years as one of his closest deputies.
NEWS
November 13, 1999 | MARLENE CIMONS, TIMES STAFF WRITER
Spurred by recent research, the Food and Drug Administration on Friday proposed that all food labels list levels of trans fatty acids, which clog arteries and cause coronary heart disease, the nation's leading killer. "Trans fats," as trans fatty acids are also known, are produced by a process known as hydrogenation and are often used to give foods better texture and taste and longer shelf life. Chief culprits: cookies, pastries, crackers, deep-fried foods and stick margarines.
NEWS
December 23, 1998 | DAVID WILLMAN, TIMES STAFF WRITER
Saying that the issues "go to the heart of the public's confidence" in the Food and Drug Administration, three senior House Democrats are seeking answers to extensive questions about the agency's approval of the diabetes pill Rezulin. In a four-page letter to Dr. Jane E. Henney, the newly installed FDA commissioner, Reps. John D. Dingell of Michigan, Sherrod Brown of Ohio and Henry A.
NEWS
July 12, 2000 | MARLENE CIMONS, TIMES STAFF WRITER
The Food and Drug Administration on Tuesday approved the first robotic medical device that performs surgery. The technology, surgeons say, eventually could transform highly invasive operations, such as open-chest heart surgery, by enabling doctors to use only small incisions.
Los Angeles Times Articles
|